Abbott Laboratories SEC filings ABT
Abbott Laboratories has 1,001 filings in SEC EDGAR's recent list, going back to Jul 12, 2018. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 13, 2026 | — |
| DEF 14A | Proxy statement | Mar 13, 2026 | Apr 24, 2026 |
| DEFA14A | Additional proxy material | Mar 14, 2025 | — |
| DEF 14A | Proxy statement | Mar 14, 2025 | Apr 25, 2025 |
| DEFA14A | Additional proxy material | Mar 15, 2024 | — |
| DEF 14A | Proxy statement | Mar 15, 2024 | Apr 26, 2024 |
| DEFA14A | Additional proxy material | Mar 17, 2023 | — |
| DEF 14A | Proxy statement | Mar 17, 2023 | — |
| DEFA14A | Additional proxy material | Mar 18, 2022 | — |
| DEF 14A | Proxy statement | Mar 18, 2022 | Apr 29, 2022 |
| DEFA14A | Additional proxy material | Mar 12, 2021 | — |
| DEF 14A | Proxy statement | Mar 12, 2021 | Apr 23, 2021 |
| PRE 14A | Preliminary proxy statement | Feb 25, 2021 | Apr 23, 2021 |
| DEFA14A | Additional proxy material | Apr 14, 2020 | — |
| DEFA14A | Additional proxy material | Mar 13, 2020 | — |
| DEF 14A | Proxy statement | Mar 13, 2020 | Apr 24, 2020 |
| DEFA14A | Additional proxy material | Mar 15, 2019 | — |
| DEF 14A | Proxy statement | Mar 15, 2019 | Apr 26, 2019 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- IL
- Headquarters
- Abbott Park, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1800
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.